Immunotherapy + CRT Boosts Response in Esophageal Cancer ...Middle East

The addition of sintilimab to neoadjuvant chemoradiotherapy achieved a 60% pathological complete response rate vs 47.3% with chemoradiotherapy alone in locally advanced ESCC. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Immunotherapy + CRT Boosts Response in Esophageal Cancer )

Also on site :

• Why Steve Sarkisian and oddsmakers are exactly right about the new era of the SEC
• New federal Covid-19 vaccine policies are already keeping some people from getting shots
• Robert De Niro, 81, Makes Rare Public Appearance With Daughter Helen, 13